Home / Europe / Bosnia and Herzegovina / Life Sciences & Healthcare

Life Sciences & Healthcare Law Firm in Bosnia and Herzegovina

With over 480 international specialist lawyers across CMS and the support of the Life Sciences Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your life sciences & healthcare business. We work with and have established long-term relationships with the top 100 life sciences & healthcare companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.

Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations we help shape the legal frameworks impacting the life sciences & healthcare sector.

We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice and compliance. Equally, when you need life sciences & healthcare specialist advice for strategic agreements, planning a corporate transaction or embarking on litigation (whether product liability or otherwise), we have a team that is well versed in the industry issues to help you.

Choose area

mobile health mask
E-Prescription: Digitalizing Health Care
 .

Feed

30/01/2024
What’s in a name? Updated EMA guideline on naming medicinal products processed...
The updated EMA Guideline on the acceptability of names for human medicinal products processed through the centralised procedure was adopted by CHMP in December 2023 and came into effect on 1 January...
08/12/2023
COP28: Global Health Under the Spotlight
Health took centre stage at the first ever ‘Health Day’ at COP28 on 3 December. The program focused the attention of world leaders on the profound public health-related issues stemming from climate...
08/11/2023
CMS Life Sciences Vital Signs, Winter 2023
2023 has seen some significant legal developments impacting the life sciences industry, and as we look ahead to 2024, there are several important developments which we would like to keep our clients informed...
08/11/2023
Cannabis law and legislation in Bosnia & Herzegovina
Medical use The medical use of cannabis is not regulated in Bosnia and Herzegovina as such. However, the Law on Prevention and Suppression of Narcotic Drugs Abuse of Bosnia and Herzegovina only permits...
28/09/2023
EP Case Law in Brief: Erroneous Disclosures
“Mistakes in a document do not in themselves constitute prior art such as to prevent the grant of a patent.”So begins section I.C. 4.9 of the Case Law of the Boards of Appeal. This statement, and...
15/08/2023
AI in healthcare inventions – technical or not technical?
SummaryRecent European Patent Office (EPO) Board of Appeal case T 1910/20 sits among a number of decisions regarding the discussion of what constitutes technical character in the field of healthcare...
12/06/2023
CMS updates Global Expert Guide to Digital health apps and telemedicine
Digitisation is advancing steadily. Its pioneering innovations challenge all parties involved.One of the most important aspects in this area is the huge potential that lies in the digitisation of healthcare.In...
02/05/2023
CMS updates Expert Guide on cannabis law and legislation
CMS Expert Guide on cannabis law and le­gis­la­tion gives stakeholders detailed and updated information on the latest developments in cannabis regulation in key markets. The Guide now covers two new jur­is­dic­tions:...
13/04/2023
CMS series: At CEEnter stage
Our engaging podcast and video series, "At CEEntre Stage," is a valuable resource for professionals and legal advisors seeking in-depth insights into various Corporate and M&A topics. Our series caters to diverse businesses in Central and Eastern Europe, providing comprehensive coverage of the ongoing challenges they face. Half-hour moderated discussions with legal experts and industry leaders allow us to gain valuable insights into their vision for the future, the challenges they face, and ways to improve their businesses. We also provide guidance on navigating legal complexities and avoiding potential traps, ensuring our listeners receive contextualized insights into the region's distinctive business landscape and regulatory environment. Our comprehensive coverage of various industries and their ongoing challenges makes "At CEEntre Stage" an essential resource for staying ahead of the curve in today's fast-paced economy. The podcast covers relevant Corporate and M&A topics from W&I insurances, FDI to ESOP, joint ventures, financing and ESG. Tune in to "At CEEntre Stage" today and stay informed on the latest insights and trends in the world of corporate law and M&A.
04/04/2023
European Commission amends Article 102 TFEU guidance paper and announces...
In 2008, the Commission adopted its Guidance on the Commission`s enforcement priorities in applying Article 82 of the EC Treaty (now Article 102 TFEU) to abusive exclusionary conduct by dominant undertakings...
03/04/2023
Rigorous European legislation bringing clarity on proper green communication
Environmental awareness and sustainability have been subjects of intense discussions since they are of growing importance to individuals in their daily decisions. Because this dimension of economic competition...
28/03/2023
European Parliament and Council ready to start negotiations on EU Data...
In February 2022 the European Commission presented its proposal for the EU Data Act, which – if adopted - will introduce a far-reaching legal regime on access to and use of non-personal data in the...